The Informatics and Gene Expression Core (IGEC) serves to provide resources and perform services for SPORE Projects I-IV as well as for future developmental and pilot projects. The IGEC will facilitate the accomplishment and integration of SPORE research objectives involving studies of large-scale gene expression in a timely and cost efficient manner, and will also serve as a resource for collaborative studies and technology evaluation and dissemination with other SPOREs. A major activity of the IGEC will be the construction and analysis of specialized cDNA arrays for largescale transcript expression studies. We are well positioned to provide this resource by virtue of our efforts to develop a prostate-centric gene expression orientation with the following resources: ..Development of an informatics resource termed the Prostate Expression Database (PEDB). ..Production and assembly of Expressed Sequence Tags (ESTs) for gene identification in prostate tissues. ..Production of cDNA libraries and sets of cDNA clones derived from a wide variety of normal and neoplastic prostate tissue components. ..Development and application of cDNA Expression Array Technology to prostate carcinogenesis. ..Development and application of Proteomics Technology to prostate carcinogenesis. The IGEC will provide: 1 .Software and hardware support for investigators using sequence homology comparison algorithms and other DNA and protein sequence analysis tools; 2. DNA/cDNA-clone sequence retrieval service to deliver specific cDNA and genomic clones to Project investigators for bench experiments; 3. High quality and rapid turn-around DNA sequencing support service to facilitate the verification of cDNA clones identified by investigators as interesting by virtue of differential expression studies; 4. High-quality cDNA microarrays with support for experimental design, procedures, and analysis of results. 5. Microarray-based Comparative Genome Hybridization (CGH). 6. Mass Spectrometry-based peptide/protein identification and quantitation with informatics support. 7. Statistical support for the analysis of large-scale transcript/protein expression data (Conjunction with Core C); 8. Database archiving of IGEC data for secure storage with rapid Website access/dissemination to Projects and collaborators. (Conjunction with Cores B and C).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA097186-01
Application #
6671835
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-19
Project End
2007-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Cheng, Heather H; Plets, Melissa; Li, Hongli et al. (2018) Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer. Prostate 78:121-127
Levesque, Christine; Nelson, Peter S (2018) Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance. Cold Spring Harb Perspect Med 8:
Barnard, Monique; Quanson, Jonathan L; Mostaghel, Elahe et al. (2018) 11-Oxygenated androgen precursors are the preferred substrates for aldo-keto reductase 1C3 (AKR1C3): Implications for castration resistant prostate cancer. J Steroid Biochem Mol Biol 183:192-201
Ganaie, Arsheed A; Beigh, Firdous H; Astone, Matteo et al. (2018) BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models. Clin Cancer Res 24:6421-6432
Schweizer, Michael T; Haugk, Kathleen; McKiernan, Jožefa S et al. (2018) A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. PLoS One 13:e0198389
Peacock, James W; Takeuchi, Ario; Hayashi, Norihiro et al. (2018) SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1. EMBO Mol Med 10:219-238
Pollan, Sara G; Huang, Fangjin; Sperger, Jamie M et al. (2018) Regulation of inside-out ?1-integrin activation by CDCP1. Oncogene 37:2817-2836
Wu, Yi-Mi; Cie?lik, Marcin; Lonigro, Robert J et al. (2018) Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. Cell 173:1770-1782.e14
Schweizer, Michael T; Hancock, Michael L; Getzenberg, Robert H et al. (2018) Hormone levels following surgical and medical castration: defining optimal androgen suppression. Asian J Androl 20:405-406
Yan, Qingxiang; Bantis, Leonidas E; Stanford, Janet L et al. (2018) Combining multiple biomarkers linearly to maximize the partial area under the ROC curve. Stat Med 37:627-642

Showing the most recent 10 out of 400 publications